Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 114999137 | 11499913 | 7 | F | 20140925 | 20160923 | 20150914 | 20160929 | EXP | CA-ROCHE-1633144 | ROCHE | 53.85 | YR | F | Y | 0.00000 | 20160929 | OT | CA | CA |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 114999137 | 11499913 | 1 | PS | XOLAIR | OMALIZUMAB | 1 | Subcutaneous | U | 103976 | 375 | MG | SOLUTION FOR INJECTION | QOW | ||||||
| 114999137 | 11499913 | 2 | SS | XOLAIR | OMALIZUMAB | 1 | Subcutaneous | U | 103976 | SOLUTION FOR INJECTION | |||||||||
| 114999137 | 11499913 | 3 | SS | XOLAIR | OMALIZUMAB | 1 | Subcutaneous | UNK | U | 103976 | SOLUTION FOR INJECTION | ||||||||
| 114999137 | 11499913 | 4 | SS | XOLAIR | OMALIZUMAB | 1 | Subcutaneous | UNK | U | 103976 | SOLUTION FOR INJECTION | ||||||||
| 114999137 | 11499913 | 5 | SS | XOLAIR | OMALIZUMAB | 1 | Subcutaneous | U | 103976 | SOLUTION FOR INJECTION | |||||||||
| 114999137 | 11499913 | 6 | SS | DIOVAN | VALSARTAN | 1 | Oral | U | 0 | ||||||||||
| 114999137 | 11499913 | 7 | C | ALVESCO | CICLESONIDE | 1 | Unknown | 0 | |||||||||||
| 114999137 | 11499913 | 8 | C | VENTOLIN | ALBUTEROL SULFATE | 1 | Unknown | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 114999137 | 11499913 | 1 | Asthma |
| 114999137 | 11499913 | 6 | Product used for unknown indication |
| 114999137 | 11499913 | 7 | Product used for unknown indication |
| 114999137 | 11499913 | 8 | Product used for unknown indication |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 114999137 | 11499913 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 114999137 | 11499913 | Blood pressure systolic increased | |
| 114999137 | 11499913 | Bronchitis | |
| 114999137 | 11499913 | Dizziness | |
| 114999137 | 11499913 | Drug hypersensitivity | |
| 114999137 | 11499913 | Fatigue | |
| 114999137 | 11499913 | Gastrointestinal disorder | |
| 114999137 | 11499913 | Headache | |
| 114999137 | 11499913 | Hyperaesthesia | |
| 114999137 | 11499913 | Hypoaesthesia | |
| 114999137 | 11499913 | Influenza | |
| 114999137 | 11499913 | Injection site hypersensitivity | |
| 114999137 | 11499913 | Malaise | |
| 114999137 | 11499913 | Musculoskeletal pain | |
| 114999137 | 11499913 | Nausea | |
| 114999137 | 11499913 | Pain | |
| 114999137 | 11499913 | Pain in extremity |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 114999137 | 11499913 | 1 | 20140911 | 0 | ||
| 114999137 | 11499913 | 2 | 20140925 | 0 | ||
| 114999137 | 11499913 | 3 | 20151105 | 0 | ||
| 114999137 | 11499913 | 4 | 20151217 | 0 | ||
| 114999137 | 11499913 | 5 | 20160825 | 0 |